MXPA04004304A - Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v. - Google Patents

Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.

Info

Publication number
MXPA04004304A
MXPA04004304A MXPA04004304A MXPA04004304A MXPA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A MX PA04004304 A MXPA04004304 A MX PA04004304A
Authority
MX
Mexico
Prior art keywords
factor
polypeptides
pharmaceutical composition
factor vii
vii
Prior art date
Application number
MXPA04004304A
Other languages
English (en)
Spanish (es)
Inventor
Rojkjaer Rasmus
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of MXPA04004304A publication Critical patent/MXPA04004304A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04004304A 2001-11-09 2002-11-05 Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v. MXPA04004304A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Publications (1)

Publication Number Publication Date
MXPA04004304A true MXPA04004304A (es) 2004-08-11

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004304A MXPA04004304A (es) 2001-11-09 2002-11-05 Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.

Country Status (16)

Country Link
EP (1) EP1446149A1 (zh)
JP (1) JP2005511599A (zh)
KR (1) KR20050043734A (zh)
CN (1) CN1596125A (zh)
AU (1) AU2002340779B2 (zh)
BR (1) BR0213953A (zh)
CA (1) CA2464615A1 (zh)
CZ (1) CZ2004543A3 (zh)
HU (1) HUP0401985A3 (zh)
IL (1) IL161544A0 (zh)
MX (1) MXPA04004304A (zh)
NO (1) NO20042380L (zh)
PL (1) PL370634A1 (zh)
RU (1) RU2004117534A (zh)
WO (1) WO2003039584A1 (zh)
ZA (1) ZA200403271B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200116B1 (en) 1999-07-14 2008-10-15 Novo Nordisk Health Care AG USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
EP1713497B1 (en) * 2004-02-05 2016-04-13 Novo Nordisk Health Care AG Use of factor viia for treating late complications of trauma
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
ES2399138T3 (es) * 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
BR112016009954A2 (pt) * 2013-11-04 2017-12-05 Univ California terapia para o tratamento ou prevenção de condições associadas a sangramento hipocoagulação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0756638T3 (da) * 1994-04-22 2001-07-23 Sanquin Bloedvoorziening Midler til behandling af forstyrrelser i blodkoagulationskaskaden
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
WO1999058699A2 (en) * 1998-05-14 1999-11-18 Battelle Memorial Institute Transgenic plant-derived human blood coagulation factors

Also Published As

Publication number Publication date
NO20042380L (no) 2004-06-08
WO2003039584A1 (en) 2003-05-15
PL370634A1 (en) 2005-05-30
IL161544A0 (en) 2004-09-27
KR20050043734A (ko) 2005-05-11
CA2464615A1 (en) 2003-05-15
AU2002340779B2 (en) 2007-08-02
HUP0401985A2 (hu) 2004-12-28
HUP0401985A3 (en) 2009-03-30
ZA200403271B (en) 2004-11-08
CN1596125A (zh) 2005-03-16
EP1446149A1 (en) 2004-08-18
CZ2004543A3 (cs) 2004-08-18
BR0213953A (pt) 2004-08-31
RU2004117534A (ru) 2005-05-10
JP2005511599A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
IL161016A (en) Polypeptides capable of ang-2 binding
YU68002A (sh) Modifikovani faktor viii
ATE386538T1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
EP2949658A3 (en) Peptides that specifically bind HGF receptor (cMet) and uses thereof
NZ504114A (en) Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
ZA200401079B (en) Modified transferrin fusion proteins
SI1346034T1 (sl) POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA
DE60120712D1 (en) Kallikrein gen
WO2003007689A3 (en) Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
GB0216001D0 (en) Process and composition
WO2003031598A3 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
MXPA04004304A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.
AU8184301A (en) Inhibitors for the blood-clotting factor xa
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
IL193310A0 (en) Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same
MXPA04004303A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1.
MX9504686A (es) Proteinas con propiedades fibrinoliticas y reductoras de la coagulacion.
EP1458736A4 (en) RECOMBINANT RINDER THROMBIN
MXPA04001526A (es) Composiciones de polipetidos kgf.
WO2002059153A3 (en) Anticoagulants and their uses
WO2002012283A3 (en) Disintegrin homologs, zsnk10, zsnk11, and zsnk12
HUP0401959A2 (hu) A VII-es faktor és PAI-1 polipeptideket tartalmazó gyógyszerészeti összetétel
AU2003223956A1 (en) Proteolysis resistant active vegf

Legal Events

Date Code Title Description
FG Grant or registration